Author information:
(1)Janssen Research & Development, LLC, Raritan, New Jersey, USA.
(2)Janssen Research & Development, LLC, Spring House, Pennsylvania, USA.
(3)Department of Hematology and Medical Oncology, Winship Cancer Institute, 
Emory University, Atlanta, Georgia, USA.
(4)VU University Medical Center, Amsterdam, The Netherlands.
(5)Division of Hematology/Oncology, Lineberger Comprehensive Cancer Center, 
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
(6)Vejle Hospital and University of Southern Denmark, Vejle, Denmark.
(7)Janssen Research & Development, Beerse, Belgium.